DGAP-News: Epigenomics AG / Key word(s): Capital Increase 08.10.2018 / 14:55 The issuer is solely responsible for the content of this announcement. Press release NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, JAPAN AND AUSTRALIA. Epigenomics AG: Capital increase through rights issue with subscription rights […]
Category: Press Releases
08. October 2018
Epigenomics AG: Capital increase through rights issue with subscription rights of existing shareholders
Read more
02. October 2018
Epigenomics AG: U.S. Congress supports CMS coverage of colorectal cancer screening blood tests
DGAP-News: Epigenomics AG / Key word(s): Miscellaneous 02.10.2018 / 08:30 The issuer is solely responsible for the content of this announcement. Press release Epigenomics AG: U.S. Congress supports CMS coverage of colorectal cancer screening blood tests Berlin (Germany) and San Diego, CA (U.S.A.), October 2, 2018 – Epigenomics AG (Frankfurt Prime Standard: ECX, OTCQX: EPGNY) […]
10. August 2018
Epigenomics (ECX-DE): Liver boost – less dependency on epiColon
goetzpartners securities Limited 10-Aug-2018 / 11:08 GMT/BST Free to access research and investor meetings in a post-MiFID2 world. This research report is intended for use only by persons who qualify as professional investors or eligible counterparties (institutional investors) in the applicable jurisdiction, and not by any private individuals or other persons who qualify as retail […]
08. August 2018
Epigenomics AG Announces 2018 Second Quarter and Six Month Financial Results
DGAP-News: Epigenomics AG / Key word(s): Half Year Results 08.08.2018 / 08:15 The issuer is solely responsible for the content of this announcement. Press release Epigenomics AG Announces 2018 Second Quarter and Six Month Financial Results Berlin (Germany) and San Diego, CA (U.S.A.), August 8, 2018 – Epigenomics AG (Frankfurt Prime Standard: ECX, OTCQX: EPGNY) […]
02. July 2018
Epigenomics AG: Liquid Biopsy Test for Liver Cancer Detection to obtain CE Mark
DGAP-News: Epigenomics AG / Key word(s): Product Launch 02.07.2018 / 07:40 The issuer is solely responsible for the content of this announcement. Press release Epigenomics AG: Liquid Biopsy Test for Liver Cancer Detection to obtain CE Mark – Epigenomics plans to CE Mark mSEPT9 blood test for liver cancer by year-end 2018, enabling commercialization in […]
11. June 2018
Epigenomics AG: Centers for Medicare & Medicaid Services publish preliminary rate for Epigenomics’ colorectal cancer screening test Epi proColon(R)
DGAP-News: Epigenomics AG / Key word(s): Miscellaneous 11.06.2018 / 08:37 The issuer is solely responsible for the content of this announcement. Press release Centers for Medicare & Medicaid Services publish preliminary rate for Epigenomics’ colorectal cancer screening test Epi proColon(R) Medicare Administrative Contractors determine rate of $192 per test Berlin (Germany) and Germantown, MD (U.S.A.), […]